All In MedTech

FDA Clearance Tracker · P000057-S011

Ascension MCP

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 5, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 5, 2019

Approved

Time to decision

146 days

Received Oct 10, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P000057-S011
Device name
Ascension MCP
Applicant location
Cordova, TN
Received
Oct 10, 2018
Decided
Mar 5, 2019
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P000057

Device type

Device class
Class III

Every decision under product code NEG

FDA's approval statement

As written in FDA's record.

Approval for labeling changes to the package insert, surgical technique, patient information brochure, and post-operative therapy brochure.

Source documents

Other decisions for Smith & Nephew, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.